A. Watts

发表

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

John Seibyl, Mark Stacy, Stanley Fahn, 2004, Archives of neurology.

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

John Seibyl, Anthony E. Lang, Stanley Fahn, 2000, JAMA.

Concomitant Forms of Abuse and Help-Seeking Behavior Among White, African American, and Latina Women Who Experience Intimate Partner Violence

Catherine Cerulli, Yinglin Xia, N. Talbot, 2011, Violence against women.

Oral Desipramine and Topical Lidocaine for Vulvodynia: A Randomized Controlled Trial

R. Dworkin, F. Howard, D. Oakes, 2010, Obstetrics and gynecology.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Stephanie D. Wilson, S. Ellias, J. Nutt, 2014, JAMA neurology.

Interpersonal Psychotherapy for Depressed Women With Sexual Abuse Histories: A Pilot Study in a Community Mental Health Center

Y. Conwell, N. Talbot, S. Stuart, 2005, The Journal of nervous and mental disease.

The Tampon Test for Vulvodynia Treatment Outcomes Research: Reliability, Construct Validity, and Responsiveness

R. Dworkin, F. Howard, D. Oakes, 2009, Obstetrics and gynecology.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Jane S. Paulsen, J. Jankovic, T. Brashers-Krug, 2016, JAMA.

Urate as a predictor of the rate of clinical decline in Parkinson disease.

C. Tanner, A. Lang, M. Beal, 2009, Archives of neurology.

Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients

Jose A. Santiago, Judith A. Potashkin, Arthur Watts, 2012, PloS one.

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson’s disease

L. Seeberger, E. Siemers, C. Adler, 2001, Neurology.

A randomized, double‐blind, placebo‐controlled trial of pridopidine in Huntington's disease

B. Leavitt, F. Walker, A. Siderowf, 2013, Movement disorders : official journal of the Movement Disorder Society.

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.

L. Seeberger, L. Raymond, R. Barker, 2013, JAMA neurology.

Substance-induced depression and independent depression in proximal risk for suicidal behavior.

K. Conner, R. Houston, M. Swogger, 2014, Journal of studies on alcohol and drugs.

Pain and depression in gynecology patients.

D. Giles, K. Kroenke, X. Tu, 2009, Psychosomatics.

Safety and tolerability of high‐dosage coenzyme Q10 in Huntington's disease and healthy subjects

D. Jennings, M. Beal, R. Ferrante, 2010, Movement disorders : official journal of the Movement Disorder Society.

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

J. Jankovic, P. Tariot, B. Leavitt, 2022, CNS Drugs.

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

A. Lang, J. Seibyl, S. Fahn, 2008, Archives of neurology.

Evaluation of the Commitment to Living (CTL) curriculum: a 3-hour training for mental health professionals to address suicide risk.

Anthony R. Pisani, K. Conner, A. Watts, 2012, Crisis.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Jane S. Paulsen, Megan M. Romer, J. Jankovic, 2016, JAMA neurology.

Pramipexole in Levodopa-treated Parkinson Disease Patients of African, Asian, and Hispanic Heritage

C. Tanner, R. Pahwa, J. Carter, 2007, Clinical neuropharmacology.

Stressful life events and suicidal behavior in adults with alcohol use disorders: role of event severity, timing, and type.

P. Duberstein, Y. Conwell, K. Conner, 2012, Drug and alcohol dependence.

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

J. Jankovic, L. Seeberger, L. Raymond, 2008, Archives of neurology.

·P-17 Investigator effects in a multicenter trial for parkinson's disease

M. Mcdermott, S. Plumb, I. Shoulson, 1990 .

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

A. Lang, J. Seibyl, S. Fahn, 2008, Archives of neurology.

Urate as a predictor of the rate of clinical decline in Parkinson disease.

C. Tanner, A. Lang, M. Beal, 2009, Archives of neurology.

Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease. Commentary

M. Schwarzschild, M. Schiess, A. Watts, 2008 .

Concomitant Forms of Abuse and Help-Seeking Behavior Among White, African American, and Latina Women Who Experience Intimate Partner Violence

Catherine Cerulli, Yinglin Xia, N. Talbot, 2011, Violence against women.

Models for surveillance data under reporting delay: applications to US veteran first-time suicide attempters

Naiji Lu, Hua He, Yinglin Xia, 2015 .

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

J. Jankovic, L. Seeberger, L. Raymond, 2008, Archives of neurology.